2 Bargain Stocks to Buy With $1,000 in November
Key PointsDrugmaker Pfizer has a brighter future than its stock’s recent performance suggests. You just need to look a little further down the road than most investors typically do.
As the third-quarter earnings season concludes, investors are contemplating adjustments to their portfolios. This article presents two promising bargain stocks suitable for long-term portfolios.
Firstly, Pfizer Inc. (PFE) is a pharmaceutical giant experiencing a period of uncertainty. Despite ongoing COVID-19 trials, Pfizer's revenue has fallen short of 2022's highs, and patent expirations threaten some top-selling drugs. However, the company is actively investing in its research and development pipeline, with a goal to double its cancer patient base by 2030. Pfizer's shares, trading at just 10 times expected earnings and offering a 6% dividend yield, present an undervalued opportunity.
Secondly, Alphabet Inc. (GOOGL), the parent company of Google, is another attractive bargain. Although its stock price is usually premium, it's currently trading at less than 20 times expected earnings. The company's robust search engine and Android dominance, coupled with its AI investments, make Google a strong contender in the digital market. Analysts remain bullish on Alphabet, with a consensus buy rating and a potential upside of over 30%.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
